| PDN Post Market, Multicenter, Prospective, Global Clinical Study (NCT05301816) | Nevro Corp | 2022-07-05 |
| Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms (NCT04988321) | Virginia Commonwealth University | 2021-09-03 |
| The Effect of Foot and Ankle Exercise on Pain and Quality of Life in Patients With Diabetic Neuropathy (NCT05670600) | Gazi University | 2021-07-04 |
| Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy (NCT04469270) | Helixmith Co., Ltd. | 2020-11-20 |
| The Effect of Foot Reflexology and Foot Bath on Paın And Qualıty of Lıfe Applıed to Dıabetıc Neuropathıc Paın (NCT05920434) | Adiyaman Provincial Health Directorate | 2020-07-19 |
| Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain (NCT03315598) | Seoul National University | 2017-05-15 |
| Phase 3 Gene Therapy for Painful Diabetic Neuropathy (NCT02427464) | Helixmith Co., Ltd. | 2016-04-01 |
| Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain. (NCT03047278) | Natalia Valadares de Moraes | 2015-11-01 |
| A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) (NCT02215252) | Pfizer | 2014-11-10 |
| Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral Neuropathy (NCT01793350) | BioChemics, Inc. | 2013-06-01 |
| Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021) (NCT01564459) | Merck Sharp & Dohme LLC | 2012-03-26 |
| Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy (NCT01332149) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-07-01 |
| A Study in Participants With Diabetic Peripheral Neuropathic Pain in China (NCT01179672) | Eli Lilly and Company | 2011-04-01 |
| Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy (NCT01214590) | VascuActive LTD | 2011-03-01 |
| Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy. (NCT05029297) | Arafarma Group, S.A. | 2010-11-04 |
| Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy (NCT01057693) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-03-31 |
| A Study in Painful Diabetic Neuropathy (NCT01089556) | Eli Lilly and Company | 2010-03-01 |
| A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN) (NCT01063868) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-01-01 |
| A Study for Treatment of Pain in Patients With Diabetic Neuropathy. (NCT00785577) | Eli Lilly and Company | 2008-11-01 |
| A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy (NCT00553280) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-02-01 |
| Thermal Biofeedback for the Treatment of Diabetic Neuropathy (NCT00858351) | Northwestern University | 2007-11-01 |
| Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy (NCT00553475) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-10-01 |
| Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain (NCT00507936) | AbbVie (prior sponsor, Abbott) | 2007-08-01 |
| Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). (NCT00501202) | SK Life Science, Inc. | 2007-03-01 |
| Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy (NCT00381719) | Allergan | 2006-10-01 |
| An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain (NCT00385671) | Eli Lilly and Company | 2006-09-01 |
| Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy (NCT01050218) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-07-01 |
| Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy (NCT01628627) | Lorenz Biotech S.p.A. | 2006-05-01 |
| Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain (NCT00266643) | Eli Lilly and Company | 2005-12-01 |
| A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN) (NCT00156078) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-01-01 |
| Treatment of Painful Diabetic Neuropathy With Photon Stimulation (NCT00539175) | East Bay Institute for Research and Education | 2004-10-01 |
| Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy (NCT00159679) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-09-01 |
| Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy (NCT00073034) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-01-01 |
| A Study for the Treatment of Painful Diabetic Neuropathy (NCT00058968) | Eli Lilly and Company | 2002-10-01 |
| Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy. (NCT00141401) | Pfizer | 1999-09-01 |